Cameron Harkness, MD
Obstetrics & Gynecology · Asheville, NCNPI 1780626093
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (55.2%), food and beverage and education — rather than concentrated in one kind of arrangement. 16 manufacturers reported payments, led by Carl Zeiss Meditec, Inc. at 58.6% of the total. Reporting peaked in 2020 at $975 and has fallen 74.3% since, to $251 in 2025.
Across 30 payments — averaging $54.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Carl Zeiss Meditec, Inc.$964
- Eisai Inc.$129
- Seagen Inc.$119
- Pfizer$53
- AbbVie$50
- Merck$49
- plus $279 from 10 others
Across 33 payments — averaging $2174.89 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AbbVie$56K
- Eisai Inc.$14K
- Amgen$2K
What the payments were for
- Travel & lodging$90655%
- Food & beverage$61437%
- Education$1237%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Carl Zeiss Meditec, Inc. | 2 | $964 |
| Eisai Inc. | 6 | $129 |
| Seagen Inc. | 2 | $119 |
| Pfizer | 4 | $53 |
| AbbVie | 2 | $50 |
| Merck | 2 | $49 |
| GSK | 2 | $47 |
| AstraZeneca | 2 | $45 |
| Caris MPI, Inc. | 1 | $36 |
| Daiichi Sankyo Inc. | 1 | $30 |
| Novartis | 1 | $25 |
| Tactile Systems Technology Inc | 1 | $23 |
| Elucent Medical | 1 | $22 |
| Lilly USA, LLC | 1 | $20 |
| Myriad Genetic Laboratories, Inc. | 1 | $19 |
| Genmab U.S., Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- IORT$906
How this compares
$1,643 in reported general payments places this provider in the 75th percentile of 1,344 obstetrics & gynecology providers in North Carolina.
See all obstetrics & gynecology providers in North Carolina →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Anastrozole | 116 | $2,124 |
| Letrozole | 33 | $421 |
| Gabapentin | 27 | $321 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Asheville
- Karie LafleurAsheville$135K
- Breanna BolivarAsheville$45K
- Stacy TravisAsheville$27K
- Rita KaplonAsheville$14K
- Jerry MatkinsCharlotte$481K
- Laura McKainWilmington$475K
- Leslie Hansen-LindnerCharlotte$372K
- Robin MatthewsClyde$217K
- Haywood BrownDurham$165K
- Jack IngeRaleigh$157K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.